Effect of Aspirin on Abacavir-induced Platelet Reactivity in HIV-infected Patients
Status:
Completed
Trial end date:
2017-10-12
Target enrollment:
Participant gender:
Summary
The specific research questions addressed in the present study are:
- to investigate the impact of treatment with low-dose aspirin in HIV-1-infected patients
treated with ABC and test it would result in decreased in vivo platelet activation and
platelet hyperreactivity
- to investigate if aspirin has the same effects in HIV-infected as in HIV-uninfected
patients.